Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Michael Cameron

Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling

scientific article published on 28 January 2021

Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors

scientific article published on February 27, 2013

Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (Part-II)

scientific article published on December 1, 2011

Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I)

scientific article published on September 24, 2011

Discovery of a Highly Selective CYP3A4 Inhibitor Suitable for Reaction Phenotyping Studies and Differentiation of CYP3A4 and CYP3A5

scientific article published on June 13, 2012

Discovery of small-molecule enzyme activators by activity-based protein profiling

scientific article published on 08 June 2020

Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists

scientific article published on May 4, 2012

Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains

scientific article published on November 24, 2011

Imidazopyridines as selective CYP3A4 inhibitors

scientific article published on 04 January 2012

Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition

scientific article published on 17 June 2020

JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease

scientific article published on April 20, 2011

Orexin-1 Receptor Mediation of Cocaine Seeking in Male and Female Rats

scientific article published on December 20, 2011

Oxidative Metabolism as a Modulator of Kratom’s Biological Actions

Potential Role of a Quetiapine Metabolite in Quetiapine-Induced Neutropenia and Agranulocytosis

scientific article published on April 25, 2012

Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease

scientific article published on April 20, 2011

Small molecule 1a reduces FMRpolyG-mediated toxicity in in vitro and in vivo models for FMR1 premutation

scientific article published on 01 August 2021

Synthesis and Biological Evaluation of Urea Derivatives as Highly Potent and Selective Rho Kinase Inhibitors

scientific article published on April 25, 2013

Synthesis and SAR of 2-Phenoxypyridines as novel c-Jun N-terminal kinase inhibitors

scientific article published on September 29, 2011

Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors

scientific article published on December 2010

Synthesis and SAR of Lehualide B: A Marine-Derived Natural Product with Potent Anti-Multiple Myeloma Activity

scientific article published on 02 April 2013

Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors

scientific article published on January 22, 2011

Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors

scientific article published on January 14, 2011

Tetrahydroisoquinoline Derivatives As Highly Selective and Potent Rho Kinase Inhibitors

scientific article published on August 12, 2010